SecFilingDex
10-KSMMTCIK 0001599298

Summit Therapeutics Inc.

Annual report (10-K) filed .

Comprehensive annual report filed by U.S. public companies, including audited financial statements, MD&A, and risk factors.

Filing facts

Accession number
0001599298-24-000031
Filer
Summit Therapeutics Inc.
Ticker
SMMT
CIK
0001599298
Form type
10-K
Form description
Annual report
Filed at
February 20, 2024
Period of report
2023-12-31
Filing size
10.0 MB
Last verified
August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.